soft.report Blog
Daily news on ophthalmology and artificial intelligence in medicine: studies, regulatory approvals and eye imaging updates, with sources in every post.
-
OCT segmentation algorithms disagree in neovascular AMD and should not be used interchangeably
A study in Eye compared two automated OCT segmentation programs in 50 patients with neovascular AMD and found clinically meaningful differences, including 43.54 μm in central total retinal thickness.
-
IOP from an implantable sensor tracked visual field progression in glaucoma
In a 9-eye study published in the BJO, mean IOP recorded by a sulcus-implanted sensor was associated with visual field progression in primary open-angle glaucoma, whereas single in-office Goldmann readings were not.
-
New polygenic risk score sharpens risk stratification for open-angle glaucoma
A study in Ophthalmology found that people in the top decile of a new polygenic score had about a 10-fold higher risk of open-angle glaucoma and, on average, were diagnosed about 25 years earlier than those in the bottom decile.
-
Physicians struggled to detect AI malfunctions in a randomized study
In a randomized study of 48 physicians published in npj Digital Medicine, diagnostic accuracy fell along with the reliability of a cardiac auscultation AI, and only 12.5% spontaneously noticed the system was failing.
-
Audit finds duplicated OCT scans in public glaucoma datasets used to validate AI
A JAMA Ophthalmology study found that two public glaucoma datasets share at least 1,031 identical OCT volumes, inflating a classifier's AUC from 0.78 to 0.90 when one dataset was used for training and the other for testing.
-
FDA requires NAION warning on labels of all GLP-1 receptor agonists
The FDA now requires every GLP-1 receptor agonist, from semaglutide to tirzepatide, to carry a labeling warning about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
Ophthalmology reports in your own template
The AI reads the exam, drafts the report in your template, and you review and sign. 15-day free trial, no card.
Discover soft.report